by S Kangkarn 2024Objective: Comparison of lipid low-density lipoprotein cholesterol (LDL) levels before and after switching from rosuvastatin or atorvastatin to simvastatin.
by S Kangkarn 2024Conclusion: In the patients who were switched from atorvastatin and rosuvastatin to simvastatin, LDL levels before and after being switched was not
by S Kangkarn ) The primary objective: Comparison of. LDL levels before and after switching from rosuvastatin or atorvastatin to simvastatin in an equivalent dose. 2) The
doses the switch to the fixed dose combination of the Effects of rosuvastatin versus atorvastatin, simvastatin and pravastatin on non-high-density
Results: Patients switched to rosuvastatin or simvastatin were similar in age, sex, and baseline LDL-C (mean, 146 mg/dL). Patients switched to
switching from another statin, the appropriate CRESTOR Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin
by S Kangkarn 2024Objective: Comparison of lipid low-density lipoprotein cholesterol (LDL) levels before and after switching from rosuvastatin or atorvastatin to simvastatin.
When initiating CRESTOR therapy or switching from another statin, the appropriate CRESTOR rosuvastatin versus simvastatin on lowering levels of
The statins showing largest change when one switches from r = 9.5 A ̊ to r statins: atorvastatin, rosuvastatin simvastatin, and fluvastatin. The
Comments